Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy.
Immunotherapy
; 12(15): 1139-1148, 2020 10.
Article
in English
| MEDLINE | ID: covidwho-771605
ABSTRACT
Aim:
Evaluating the incidence and course of COVID-19 in cancer patients treated with immunotherapy. Patients &methods:
We reported the influenza-like illness events with diagnosis of COVID-19 within the patient cohort enrolled in the prospective observational multicenter INVIDIa-2 study in the single center of Parma.Results:
Among 53 patients, eight experienced influenza-like illness during the influenza season 2019/2020, and three of them had diagnosis of COVID-19. They were males, elderly, with cardiovascular disease. Radiological features of COVID-19 pneumonitis were found in all of three cases, although the pharyngeal swab resulted positive in only two. Two of these three patients died due to respiratory failure.Conclusion:
Cancer patients are at high risk of severe events from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Immunotherapy
/
Neoplasms
Type of study:
Cohort study
/
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
English
Journal:
Immunotherapy
Journal subject:
Allergy and Immunology
/
Therapeutics
Year:
2020
Document Type:
Article
Affiliation country:
Imt-2020-0211
Similar
MEDLINE
...
LILACS
LIS